Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 251 - 300 out of 6,641

Document Document Title
WO/2014/114729A1
The present invention relates to a compound of the following formula (I) or to a salt, hydrate, or pharmaceutically acceptable solvate thereof, in which R is a monosaccharide or disaccharide residue. The hydroxyl functions of the monosac...  
WO/2014/102315A1
The application relates to the macrolide compound of the formula (I): wherein * indicates a stereocentre which is in (R) or (S) configuration, or a pharmaceutically acceptable salt or ester thereof and their use as PDE4 inhibitors.  
WO/2014/094404A1
Disclosed is an avermectin raw material, where the purity of avermectin B2a is ≥ 30%. Also disclosed is an avermectin pesticide. Same uses avermectin B2a as an active ingredient, while at the same time comprises at least one agronomica...  
WO/2014/094405A1
Disclosed is a method for extraction and preparation of avermectin B2a. The method comprises: an avermectin fermentation solution is prepared into a dry mycelium and leached; a leach liquor is concentrated, and extraction agents such as ...  
WO/2014/085958A1
The erythromycin derivatives of the present invention, i.e., hydrated crystals of erythromycin stearate, has low moisture absorption and good storage stability, and is suitable for preparing drugs for treating and preventing infectious d...  
WO/2014/064731A1
A method of obtaining a rutin-rich extract from a plant and a rutin-rich extract of Uncaria elliptica thus obtained.  
WO/2014/066318A1
The present invention relates to combination therapies for treating Alzheimer's disease or an amyloidosis-associated pathological condition comprising co-administering a therapeutically effective amount of a first compound, and a therape...  
WO/2014/059436A1
Site-selective functionalization of Amphotericin B has been achieved by simply modifying the electronic nature of the reagents. A Hammett analysis is consistent with linking of this phenomenon to the Hammond postulate: electronic tuning ...  
WO/2013/037818A3
The invention relates to a beverage comprising as a natural preservative a glycolipid of the formula (I) where n is 2, R1 is identical or different and denotes H or COCH3, R2 is identical or different and denotes H or (a), wherein m is 1...  
WO/2014/055297A1
The present invention provides a compound of Formula I:, or a pharmaceutically acceptable salt thereof.  
WO/2014/049356A1
The invention provides novel antibiotics, pharmaceutical compositions containing them and their medical use, for example in the treatment or prevention of microbial infections. Provided are compounds of Formula I, pharmaceutically accept...  
WO/2014/050894A1
The present invention provides the compound represented by formula (1) (in the formula: X1 and X2 each independently represent -OR1, -NR2R3, -CR4R5R6, or the like; R1, R2, R3, R4, R5, and R6 each independently represent a glycosyl group ...  
WO/2014/019685A1
The present invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same and to their use for the treatment of cancer and other diseases.  
WO/2014/016361A1
The present invention relates to multimeric mannosides, a process for preparing the same and their uses in medicine for treating Escherichia Coli infections. Exemplary compounds are:  
WO/2013/189237A1
Disclosed are a novel andrographolide derivative and analogue as well as a preparation method of the novel andrographolide derivative and analogue and an application to the treatment, the prevention and the relief on human viruses and ne...  
WO/2013/191550A1
The invention relates to the field of chemical derivatization. In particular, it relates to modified aminoglycosides, such as antibiotics, and methods for producing them. Provided is a method for the regioselective diazotation of a desox...  
WO/2013/186384A1
The invention provides semisynthetic N-substituted derivatives of the antifungal antibiotic Amphotericin B and water soluble salts and complexes, pharmaceutical compositions and plant and building treatment products comprising the deriva...  
WO/2013/186546A1
Complexes The invention provides aprocess for the preparation of a complex of Amphotericin B with poly(glutamic acid), which comprises the steps of i) mixing Amphotericin B with poly(glutamic acid) in the presence of water to form an aqu...  
WO/2013/170142A1
The present invention provides solid state forms of Fidaxomycin, processes for preparing the solid state forms, as well as pharmaceutical compositions and formulations comprising one or more of the solid state forms of Fidaxomycin, and p...  
WO/2013/155849A1
The present invention relates to the field of drug synthesis. Disclosed is a method for preparing 5,6,4'-trihydroxyflavone-7-0-D-glucuronic acid. The method for preparing 5,6,4'-trihydroxyflavone-7-0-D-glucuronic acid of the present inve...  
WO/2013/149577A1
Provided in the present invention are novel key intermediates of Selamectin and the preparation method thereof. Also provided is a new synthesis process, using Doramectin as a starting material, and obtaining Selamectin via hydrogenation...  
WO/2013/139344A1
3-O-Fucosyllactose is made by process which includes the hydrogenolysis of a new compound of the formula 1 wherein R1 and R2 are independently a group removable by hydrogenolysis, and R3 is a group removable by hydrogenolysis or H; or a ...  
WO/2013/131270A1
Disclosed is a Scutellarin hydrate of formula C21H18O12·nH2O, wherein n is a number between 1.75-2.0. Also disclosed in the present invention is the preparation method and use thereof. The hydrate has good storage stability, and is suit...  
WO/2013/132014A1
The invention provides semisynthetic derivatives of Nystatin A1, water soluble salts and complexes, pharmaceutical compositions and plant protection products comprising the derivatives and their use, as antifungal antibiotics (Formula 1a).  
WO/2013/134415A1
The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula I: The invention also provides pharmaceutically acceptable compositions containing the compounds and m...  
WO/2013/112897A1
Compositions and methods for stabilizing biomolecules are disclosed. Specifically, the compositions include novel homopolymers or copolymers containing trehalose side chains conjugated to biomolecules. When such homopolymers or copolymer...  
WO/2013/109927A2
It is an object of the present invention to provide antimicrobial metallodrugs comprising an antimicrobial peptide ("AMP") and/or an antibiotic covalently bound to a metal binding moiety. These metallodrugs combine a metal binding domain...  
WO/2013/100315A1
The present invention relates to a novel polyene compound similar to nystatin, method for preparing same, and an antifungal drug comprising the novel polyene compound as an active ingredient. Compared to nystatin comprising one sugar, NP...  
WO/1999/012552A8
9a-Azalides are useful in the treatment and prevention of bacterial respiratory and enteric infections in livestock animals, particularly in cattle and swine.  
WO/2013/092753A1
The present invention encompasses compounds having general formula (I) able to inhibit the lactate production (lactic acid) involved in the angiogenesis of tumoral tissues, in the glycolytic metabolic process of tumoral cells, of immune ...  
WO/2013/086621A1
The present document describes a method for extracting anthocyanin derivatives from a plant source. The method comprises the step of separating a homogenized extract of plant source in a polar acidified solvent for obtaining a residual s...  
WO/2013/076169A1
The present invention relates to new macrolide derivatives, in particular new tylosin derivatives of the formula (I); a pharmaceutical or veterinary composition comprising the derivatives; a method for preparation thereof; a method for t...  
WO/2013/059927A1
The present application relates to the compounds of formula I (I) as well as their use for inhibiting at least one of AKT-1, FAK and PKCα and in the treatment and/or prevention of metastatic diseases.  
WO/2012/162412A3
The present invention includes compositions comprising a synergistic fungicidal combination of a polyene fungicide and at least, one lipopeptide and methods for using such compositions in controlling fungal pathogens.  
WO/2013/050497A1
The present invention relates to a process of preparation of L-iduronic acid and derivatives comprising a decarboxylation/intramolecular cyclisation tandem reaction. The present invention also relates to the intermediates of the process,...  
WO/2013/029497A1
Disclosed is a preparation process of erythromycin thiocyanate, which belongs to the pharmaceutical field. The preparation process provided by the invention uses erythromycin or its salt(s) as raw material(s), dissolves it/them in aceton...  
WO/2012/166705A3
Described herein are hydrogelators that include a nucleobase, an amino acid, and a glycoside. The hydrogelators have increased resistance to proteases and can self-assemble into supramolecular nanofibers or hydrogels. The supramolecular ...  
WO/2013/023338A1
Provided is a pharmaceutical composition useful for prevention and/or treatment of diseases caused by bacteria, wherein the pharmaceutical composition comprising a honeysuckle extract containing iridoid compounds and an antibiotic. Also ...  
WO/2013/018779A1
The purpose of the present invention is to provide: a novel crystal of α-glucosyl hesperidin, of which the crystal structure is elucidated; a powder substantially comprising the crystal; and use of the powder as a material for a medicin...  
WO/2012/172429A3
Aluminum based aqueous anthocyanin solutions and compositions are described.  
WO/2013/013834A1
The present invention describes new crystalline forms I, II and III of tulathromycin, new tulathromycin salts and processes for their preparation.  
WO/2013/012049A1
Provided are a medicinal agent and a food product, both of which prevent heart diseases such as cardiomegaly and heart failure. Specifically provided is an agent for preventing a heart disease such selected from among heart failure, card...  
WO/2013/008928A1
The purpose of the present invention is to provide a novel compound useful for the prevention or treatment of diseases such as cancerous angiogenesis, chronic rheumatoid arthritis, intimal hyperplasia, vascular atherosclerosis, hemorrhag...  
WO/2013/004116A1
The present invention relates to a compound as represented by general formula (I) and a pharmaceutically acceptable salt thereof, wherein R1 is H, hydroxyl or methoxyl; R2 is hydroxyl; R3 is heteroatom-substituted or unsubstituted organi...  
WO/2012/176804A1
The present invention addresses the problem of providing a compound having human SGLT2 inhibitory activity, a prodrug of the compound, a pharmacologically acceptable salt of the compound, and a pharmaceutical use of the compound. The pre...  
WO/2012/147102A4
The present invention relates to bioactive fractions and compounds from Dalbergia sissoo for the prevention or treatment of osteo-health related disorders. The present invention relates in the field of pharmaceutical composition that pro...  
WO/2012/117357A3
The inventions discloses a process for preparation of compounds of Formula (IX), Wherein, R is C1 -C6 alkyl, R1 is hydrogen or a hydroxyl protecting group, and R2 is hydrogen or fluorine.  
WO/2012/139134A3
Described herein, at least in part, are methods of modulating oncogenic fusion proteins.  
WO/2012/166705A2
Described herein are hydrogelators that include a nucleobase, an amino acid, and a glycoside. The hydrogelators have increased resistance to proteases and can self-assemble into supramolecular nanofibers or hydrogels. The supramolecular ...  
WO/2012/162412A2
The present invention includes compositions comprising a synergistic fungicidal combination of a polyene fungicide and at least, one lipopeptide and methods for using such compositions in controlling fungal pathogens.  

Matches 251 - 300 out of 6,641